Ji-Zhu Liu
Overview
Explore the profile of Ji-Zhu Liu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
18
Citations
86
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Liu Z, Wang B, Liu J, Liu W
J Cancer Res Ther
. 2018 Dec;
14(Supplement):S1076-S1083.
PMID: 30539849
Objective: To systematically review the effect and safety of irinotecan plus cisplatin (IP) compared with etoposide plus cisplatin (EP) in patients with previously untreated extensive-stage small cell lung cancer (E-SCLC)....
2.
Men L, Liu J, Chen H, Zhang L, Chen S, Xiao T, et al.
Cancer Cell Int
. 2018 Feb;
18:13.
PMID: 29422775
Background: G protein-coupled receptors (GPR) are involved in a wide range of physiological processes, some of which, however, can be hijacked by tumor cells. Over-expression of G protein-coupled receptors 137...
3.
Li G, Liu J, Zhang L, Liu G, Li S, Xiao T, et al.
Oncol Rep
. 2018 Jan;
39(3):1269-1275.
PMID: 29328466
Immature colon carcinoma transcript 1 (ICT1), a human mitochondrial translation release factor, is a ribosome-dependent codon-independent peptidyl-tRNA hydrolase. ICT1-deficiency has been recognized as a cell growth inhibitor of hepatoblastoma and...
4.
Liu G, Liu J, Li X, Zhang L, Li S, Xiao T, et al.
Mol Cell Biochem
. 2017 Aug;
438(1-2):191-198.
PMID: 28801778
Various eukaryotic translation initiation factors (eIFs) have been implicated in carcinoma development. Eukaryotic translation initiation factor 3 subunit D (eIF3D) has recently been shown to regulate the growth of several...
5.
Li G, Zhang L, Liu J, Chen S, Xiao T, Liu G, et al.
Biomed Pharmacother
. 2016 Jun;
81:160-165.
PMID: 27261590
Background: Pharmacological management of acute leukemia remains a challenge. A seashell protein Haishengsu (HSS) has been found to exert anticancer activities in recent in vitro studies. The aim of this...
6.
Zhang L, Du H, Xiao T, Liu J, Liu G, Wang J, et al.
Biomed Pharmacother
. 2015 Oct;
75:83-7.
PMID: 26463635
Objective: To investigate the expression of PD-1 and TIM-3 in CD3+ T cells in patients with diffuse large B-cell lymphoma (DLBCL). Methods: A retrospective analysis was conducted on data from...
7.
Song P, Zheng J, Xu J, Liu J, Wu L, Liu C
Mol Med Rep
. 2014 Dec;
11(4):2703-10.
PMID: 25435076
Idiopathic pulmonary fibrosis (IPF) is a fatal lung disease characterized by expansion of the fibroblast and myofibroblast population and extracellular matrix deposition. Although the pathogenic mechanisms of IPF remain to...
8.
Song P, Zheng J, Liu J, Xu J, Wu L, Liu C, et al.
Mol Med Rep
. 2014 May;
10(2):1030-6.
PMID: 24859686
Idiopathic pulmonary fibrosis (IPF) is a fibrotic lung disease associated with a high rate of mortality, characterised by an accumulation of fibroblasts/myofibroblasts in the fibroblastic foci (FF) and by an...
9.
Zheng J, Guan S, Xu Q, Liu J, Song P
Chin Med J (Engl)
. 2012 Aug;
125(15):2734-40.
PMID: 22931983
Background: Epithelial-mesenchymal transition is a cellular process characterized by the loss of cell adhesion, inhibition of E-cadherin expression, and increased cell mobility. Cells without Napsin A are susceptible to transition....
10.
Zheng J, Guan S, Xu Q, Tang Y, Liu J, Lu X
Zhonghua Yi Xue Za Zhi
. 2011 Jan;
90(46):3294-9.
PMID: 21223791
Objective: To study the in vitro effect and mechanism of Napsin A gene transfection into type II alveolar epithelial cells on pulmonary fibrosis. Methods: A recombinant lentiviral plasmid PLJM1-Napsin A...